Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism
Nobuhiro Okada, Chihiro Ueki, Masahiro Shimazaki, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
Abygail G. Chapdelaine, Gongqin Sun
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1207-1207
Open Access | Times Cited: 23
Expression and function of NF-Y subunits in cancer
Diletta Dolfini, Nerina Gnesutta, Roberto Mantovani
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189082-189082
Open Access | Times Cited: 5
Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis
Qianying Zuo, Yibin Kang
Advances in experimental medicine and biology (2025), pp. 347-370
Closed Access
Lipid dysregulation in triple negative breast cancer: Insights from mass spectrometry-based approaches
Xiaoyue Huang, Ahmed Ali, Dounia E I Yachioui, et al.
Progress in Lipid Research (2025) Vol. 98, pp. 101330-101330
Closed Access
Snord67 promotes breast cancer metastasis by guiding U6 modification and modulating the splicing landscape
Yvonne Chao, Katherine I. Zhou, Kwame K Forbes, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Lipid metabolism involved in progression and drug resistance of breast cancer
Wenxiang Fu, Aijun Sun, Huijuan Dai
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101376-101376
Open Access | Times Cited: 1
NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression
Goki Tsujimoto, Rin Ito, Kei Yoshikawa, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7
Therapeutic protein PAK restrains the progression of triple negative breast cancer through degrading SREBP-1 mRNA
Pan Hu, Peiyi Zhou, Tieyun Sun, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Paracrine Signaling Mediated by the Cytosolic Tryparedoxin Peroxidase of Trypanosoma cruzi
María Laura Chiribao, Florencia Díaz-Viraqué, María Gabriela Libisch, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 67-67
Open Access
CRISPR/Cas9 alter NFYA binding site on CD44-regulating cis-element and control CD44 expression in breast cancer cells
Sohair Salem, Shaymaa M.M. Yahya
Research Square (Research Square) (2024)
Closed Access
NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation
Guijiang Sun, Yi Shao, Qianwang Ma, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Page 1

Scroll to top